 |
 |
 |
|
INSTITUTE OF DRUG TECHNOLOGY AUSTRALIA LIMITED (IDT)
The Manager
After nearly twenty years as a Director of Institute of Drug Technology Australia Limited (IDT), Mr Green has announced that he will retire at the end of the company's next Annual General Meeting, to be held on Friday 27 October 2006. Chairman of IDT, Dr Graeme Blackman, thanked Mr Green for his outstanding contribution to the Board and its committees over the years that he has been a Director of the company. Mr.Green's active involvement in Board debates and company strategy has marked his considerable contribution to the company over the years. The Directors and Management wish Mr. Green every success in his future activities.
Established in 1975, IDT is an Australian-owned public company,
listed on the Australian Stock Exchange and employing over 140 highly
qualified scientific and support staff. The company has extensive
modern manufacturing facilities and laboratories in Melbourne and
is licensed by the Australian Therapeutic Goods Administration (TGA)
and the United States Food and Drug Administration (FDA) for the
production of pharmaceutical products. The company has become especially
well known internationally for its dedicated facilities for the
development and production of anticancer drugs. In addition, the
company offers early stage clinical trial services from its base
at the Royal Adelaide Hospital through its CMAX division (www.cmax.com.au).
|